FormularyWatch

Formulary, a monthly peer-reviewed drug management journal, provides timely, accurate, and practical drug-related topical news.

[FormularyWatch @Formulary_News]

The first part of our ultimate guide to reducing hospital readmissions is live! In this part, here's what you need to know about the HRRP, and a deep dive into lowering heart failure readmissions. https://t.co/4CLipHn2ZQ

[FormularyWatch @Formulary_News]

Novartis defends data on its $2.1 million drug https://t.co/Mqjea34STO

[FormularyWatch @Formulary_News]

The program is the latest effort by the newly merged CVS and Aetna to expand beyond retail pharmacy and insurance products and into patient healthcare services. https://t.co/rhm1OsxlRs

[FormularyWatch @Formulary_News]

Chronic pain patients on opioid therapy have limited access to primary care providers, which could lead to negative outcomes. https://t.co/6kfXbq3hc8

[FormularyWatch @Formulary_News]

FDA clears first ready-to-use insulin for IV infusion https://t.co/HtI0tgfACT

[FormularyWatch @Formulary_News]

Experts debate drug pricing policies https://t.co/FdsX1u05Ja

[FormularyWatch @Formulary_News]

EpiPen shortage: Pharma maker, retailer offer aid https://t.co/y24QUKyI10

[FormularyWatch @Formulary_News]

FDA warns opioid repackers https://t.co/Pcio8znQ0L

[FormularyWatch @Formulary_News]

The first FDA-approved device to reduce functional abdominal pain in younger patients with irritable bowel syndrome is now available to medical providers. https://t.co/Aa282jrvrK

[FormularyWatch @Formulary_News]

A record number of new #oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 #cancer drug trends revealed in the report. https://t.co/7R6TTR0iXk

[FormularyWatch @Formulary_News]

Self-injectable respiratory medication opens doors for patients with severe asthma https://t.co/geqsxRgPZC

[FormularyWatch @Formulary_News]

FDA okays cluster headache drug https://t.co/xjKMBFiM1j

[FormularyWatch @Formulary_News]

FDA clears novel breast cancer drug https://t.co/oiTAsX3xSp

[FormularyWatch @Formulary_News]

Revolutionary smartphone device could offer migraine sufferers hope https://t.co/QOfYts879C

[FormularyWatch @Formulary_News]

A closer look at some of the most important recent FDA approvals: https://t.co/hYynACiLNO

[FormularyWatch @Formulary_News]

What Express Scripts' new stand-alone digital health #formulary means for #healthcare: https://t.co/1OW9Dlf8IM

[FormularyWatch @Formulary_News]

Top 3 new drug approvals https://t.co/hYynACiLNO

[FormularyWatch @Formulary_News]

Do drug prices in ads confuse patients? https://t.co/tUZIVD0zne

[FormularyWatch @Formulary_News]

Generic drug makers are defending their practices after 44 US states accused Teva Pharmaceuticals and other pharma makers of conspiring to inflate their prices in a lawsuit. Read more: https://t.co/jc9Vazcv3o

[FormularyWatch @Formulary_News]

How Immuno-Oncology Biomarkers Are Changing Cancer Care https://t.co/hB0pNoGscB